Thomas P. Ball Professor of Residency Education
Residency Program Director
Academic Telephone: 210-567-5644
Clinical Telephone: 210-450-9600
Academic Fax: 210-567-6868
Dr. Basler received his undergraduate and MD degrees from the University of Missouri. Between these, he completed his Ph.D. in Molecular Biology at the State University of New York in Buffalo, N.Y. After a Residency in Urology at Washington University in St. Louis, Missouri, he was the recipient of a 3-year American Cancer Society Career Development Award in Urologic Oncology and stayed on as faculty at Washington University from 1990 through 1998. In 1998 he joined the faculty of the UT Health San Antonio Division of Urologic Surgery as an Associate Professor. After the Division of Urology became the Department of Urology, Dr. Basler was promoted to Professor. Dr. Basler has published numerous scientific papers, book chapters, and has edited a textbook on Urologic Oncology in addition to serving as a scientific reviewer for several prominent urologic journals. In 2008, Dr. Basler served as the President of the Texas Urologic Society, representing over 400 member Urologists. He currently serves as Program Director for UT Health San Antonio Department of Urology.
M.D., University of Missouri (1984)
Ph.D., State University of New York (1983)
MA, State University of New York (1979)
MA, University of Missouri (1976)
BA, University of Missouri (1974)
Washington University School of Medicine, Residency, Urology (1990)
University of Missouri, Internship, Surgery (1986)
Dr. Basler’s primary expertise is the diagnosis and treatment of urologic malignancies including tumors of the prostate, kidney, bladder, testis and male genitalia. He serves as a primary consultant in the GU Tumor Clinic at the South Texas Audie L. Murphy VA Hospital. Other expertise includes Endourologic procedures, stone management, treatment of Peyronie’s disease and general urology.
Dr. Basler is the Principal Investigator of several Southwest Oncology Clinical Trials open at the UT Health Science Center and STVAHCS campuses and serves on the national coordinating committee for a large VA Cooperative Trial in the treatment of advanced prostate cancer.
E. Ramahi, G.P.Swanson, F. Du, J. Basler. High-grade prostate cancer with favorable results in the modern era. 2011 Feb. (Journal of Clinical Oncology).
Brand TC, Canby-Hagino ED, Cecconi P, Basler JW. EVALUATION OF A SINGLE-STITCH VESICOURETHRAL ANASTOMOSIS AUGMENTED WITH FIBRIN SEALANTVolume
177 (4)Page: 268 Poster #803Date: 2007The Journal of UrologyAmerican Urological Association 2007. p. 268. (Journal of Urology; vol. 177, no. 4).
Hernandez J, Baillargeon J, Polock B, Basler JW,. The Association of Body Mass Index and Serum Prostate Specific antigen levels in a population-based study 2005 May. p. 401-401. (The Journal of
Urology; vol. 173, no. 4).
Basler JW, Nunes WA, Chaudhuri TK. Lymphoscintigraphic mapping of the lymphatic drainage specific regions of the prostate 2005 May. p. 432-432. (The Journal of Urology; vol. 173, no. 4).
Chaudhuri TK, Basler JW, Latoni DE, Nunes WA, Smith HL. Lymphoscintigraphic Mapping of Lymphatic Drainage of the Prostate and Seminal Vesicle 2005. p. 432. (J Nucl Med; vol. 46, no. 5).
Thompson I, Basler JW.. Screening and Early Detection for Genitourinary Cancer In: J M Potts, ed. Essential Urology: A Guide to Clinical Practice. Totowa, NJ: Humana Press; 2004. p. 47 – 60.
Hamdy, F., Basler, J., Neal, D., Catalona, W . Management of the Sequellae of Prostate Cancer: Voiding Dysfunction In: Basler, JW. Management of Urologic Malignancies. London, U.K: Churchill– Livingstone; 2002.
Magee C, Basler JW.. Bladder Carcinoma: Presentation, Diagnosis & Staging In: Basler JW, Hamdy F, Neal D, Catalona W., eds.,. Management of Urologic Malignancies. London, UK: Churchhill-Livingston; 2002.
Carbone J, Magee C, Basler JW.. Superficial Transitional Cell Carcinoma In: Hamdy, F., Basler, J., Neal, D., Catalona, W., eds.. Management of Urologic Malignancies. London, UK: Churchill- Livingston; 2002.
Basler JW. Issues and Options for Localized Prostate Cancer: Patient and Tumor Factors In: Hamdy, F., Basler, J., Neal, D., Catalona, W., eds.,. Management of Urologic Malignancies. London, UK: Churchill–Livingstone; 2002.
Bermejo C, Shepard D, Basler JW.. Prostate Cancer Treatment: Radical Prostatectomy for Early Organ-confined Disease. In: Hamdy, F., Basler, J., Neal, D., Catalona, W., eds. Management of Urologic Malignancies. London, UK: Churchhill-Livingstone; 2002.
Thompson Jr IM, Brand TC, Canby-Hagino ED, Basler JW, Troyer DA, Naylor SL, Leach RJ. Chemoprevention of prostate cancer Med Oncol Clinics of NA 2006
Basler JW. Prostate cancer screening 1994. Ann Med 1994 Jun;26(3):133-134.
Basler, MD JW. High-Grade Prostate Cancer: Favorable Results in the Modern Era Regardless of Initial Treatment ISRN Oncology 2012;2012:1-6.
Ramahi, E. H., Ansley, K.C., Swanson, G.P., Du, F., Basler JW. The Effect of Obesity and Diabetes on Intermediate to High-Grade Prostate Cancer Patients Treated with Radical Prostatectomy Open Journal of Urology 2012;2(1):20-27.
Basler, Joseph W., Holliday, Emma B., Swanson, Swanson, Gregory P., Du, Fei. Older Men with Intermediate to High-Risk Prostate Cancer- Patterns of Care and Outcomes of Treatment Journal of Cancer Therapy 2012;3(5):575-581.
Basler, MD JW. Socioeconomic disparities in prostate cancer mortality South Med J 2011 Aug;104(8):560-560.
Swanson GP, Basler JW. Prognostic factors for failure after prostatectomy Journal of Cancer 2010 Dec;2:1-19.
Sanchez-Salazar AJ, Basler JW, Nicolas MM. Intraductal carcinoma of the prostate in the ejaculatory duct. Int J Surg Pathol 2010 Aug;18(4):298-29